Conferences - Results from #10020

AUA 2016: The Problem of Undertreatment of Men with High-risk Prostate Cancer - Session Highlights May 7, 2016

AUA 2016: SUFU at the AUA Updated Neuro-Urology Terminology & Classification of Neurogenic Lower Urinary Tract Dysfunction - Session Highlights May 7, 2016

AUA 2016: Whitmore lecture—The Business of Science and the Urologic Oncologist: A Personal Journey May 7, 2016

AUA 2016: Questions Remain About HIFU Use After The FDA Weighs In on Behalf of Ablation vs. Treatment - May 7, 2016

AUA 2016: Urinary diversion for complications of radiation therapy for the treatment of prostate cancer: Updated results from the trauma and urologic research network of surgeons - Session Highlights May 7, 2016

Phallic Reconstruction Shows Promise for Achieving Functional Sexual Organ May 7, 2016

AUA 2016: SUFU at the AUA State-of-the-Art: Pathophysiology of Neurogenic Detrusor Overactivity - Session Highlights May 7, 2016

Study Suggests Chemotherapy After Radical Prostatectomy May Benefit Men Who Are At High Risk for Relapse May 7, 2016

AUA 2016: SUFU at the AUA State-of-the-Art: Pathophysiology of Detrusor Underactivity - Session Highlights May 7, 2016

AUA 2016: Predictors of long-term bladder management in spinal cord injury patients-upper extremity function matters most - Session Highlights May 7, 2016

AUA 2016: Serial botulinum toxin injections offer durable results for neurogenic bladder: 4 year urodynamic outcomes - Session Highlights May 7, 2016

AUA 2016: Trends in Supraspinal Variation in Patients with Multiple Sclerosis and Detrusor Sphincter Dyssenergia - Session Highlights May 7, 2016

AUA 2016: Efficacy and Tolerability of Mirabegron in Multiple Sclerosis: A Prospective Analysis - Session Highlights May 7, 2016

AUA 2016:The truth behind transvaginal mesh litigation: Devices, timelines, and provider characteristics - Session Highlights May 7, 2016

AUA 2016: A Measure of the Societal Impact of the FDA Transvaginal Mesh Safety Communications - Session Highlights May 7, 2016

AUA 2016: What is the role of preoperative urodynamics for women undergoing prolapse surgery? - Session Highlights May 7, 2016

AUA 2016: Role of uterine preserving surgery in mesh based pelvic organ prolapse repair. - Session Highlights May 7, 2016

AUA 2016: What’s so Difficult about A New Approach Post-BCG? - Session Highlights May 7, 2016

AUA 2016: Biomarkers of Abiraterone/Enzalutamide Resistance and Therapeutic Implications - Session Highlights May 7, 2016

AUA 2016: Mechanisms of Castration-Resistance - Session Highlights May 7, 2016

Page 502 of 589